Erkut Bahceci

Company: BlueSphere Bio

Job title: Chief Medical Officer

Seminars:

Personalized T-cell Therapy for Solid Tumours: Novel Platforms to Create Patient-Specific TCR Therapies Targeting Neoantigens 9:20 am

Uncovering NEOXpress Platform to identify, clone and express neoantigens for personalized therapies Highlighting TCXpress platform to identify effective neoantigen targeting TCRs Showcasing a quick and cost effective process to produce TCR therapies against neoantigensRead more

day: Day One

Roundtable Discussion: Discussing Strategies to Reduce Turnaround Time & Improve CostEffectiveness for More Successful Translation into the Clinic 2:40 pm

Which stage of production does the field need to focus on improving to accelerate the turnaround time? What strategies are the field currently implementing to improve the cost restraints of personalised medicines? Are there novel manufacturing methods which can be used to reduce turnaround time?Read more

day: Day One